GT200200170A - Preparacion de inhibidor de cetp anhidro - Google Patents

Preparacion de inhibidor de cetp anhidro

Info

Publication number
GT200200170A
GT200200170A GT200200170A GT200200170A GT200200170A GT 200200170 A GT200200170 A GT 200200170A GT 200200170 A GT200200170 A GT 200200170A GT 200200170 A GT200200170 A GT 200200170A GT 200200170 A GT200200170 A GT 200200170A
Authority
GT
Guatemala
Prior art keywords
cetp
inhibitor
anhidro
preparation
useful
Prior art date
Application number
GT200200170A
Other languages
English (en)
Inventor
Peter Robert Rose
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200200170A publication Critical patent/GT200200170A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/42Nitrogen atoms attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A METODOS PARA PREPARAR INHIBIDOR DE CETP ANHIDRO EL CUAL ES UTIL PARA PREVENIR LA DISMINUCION DEL COLESTEROL HDL Y EL AUMENTO DEL COLESTEROL LDL, LO CUAL ES UTIL PARA PREVENIR LA ATEROESCLEROSIS, ARTERIOPATIA CORONARIA.
GT200200170A 2001-09-28 2002-08-20 Preparacion de inhibidor de cetp anhidro GT200200170A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32592601P 2001-09-28 2001-09-28

Publications (1)

Publication Number Publication Date
GT200200170A true GT200200170A (es) 2003-05-23

Family

ID=23270027

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200200170A GT200200170A (es) 2001-09-28 2002-08-20 Preparacion de inhibidor de cetp anhidro

Country Status (28)

Country Link
US (1) US6573383B2 (es)
EP (1) EP1503987B1 (es)
JP (1) JP2005505584A (es)
KR (1) KR100629828B1 (es)
CN (1) CN1289485C (es)
AR (1) AR037325A1 (es)
AT (1) ATE346842T1 (es)
BR (1) BR0212916A (es)
CA (1) CA2461686A1 (es)
CY (1) CY1105843T1 (es)
CZ (1) CZ2004415A3 (es)
DE (1) DE60216520T2 (es)
DK (1) DK1503987T3 (es)
ES (1) ES2275902T3 (es)
GT (1) GT200200170A (es)
HK (1) HK1072424A1 (es)
HU (1) HUP0501098A3 (es)
IL (1) IL160026A0 (es)
MX (1) MXPA04002882A (es)
MY (1) MY134349A (es)
PA (1) PA8553801A1 (es)
PE (1) PE20030688A1 (es)
PL (1) PL373611A1 (es)
PT (1) PT1503987E (es)
RS (1) RS12004A (es)
UY (1) UY27454A1 (es)
WO (1) WO2003029220A2 (es)
ZA (1) ZA200400438B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR200483700Y1 (ko) 2016-02-05 2017-06-14 이요한 젓갈제조용 위생용기

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197786B1 (en) * 1998-09-17 2001-03-06 Pfizer Inc 4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
CO5271716A1 (es) * 1999-11-30 2003-04-30 Pfizer Prod Inc Cristales de 4- carboxamino 1,2,3,4-tetrahidroquinolina 2- sustituida

Also Published As

Publication number Publication date
KR20040048906A (ko) 2004-06-10
PT1503987E (pt) 2007-02-28
WO2003029220A2 (en) 2003-04-10
ZA200400438B (en) 2005-03-30
CN1612862A (zh) 2005-05-04
PE20030688A1 (es) 2003-08-11
IL160026A0 (en) 2004-06-20
DE60216520T2 (de) 2007-06-06
HUP0501098A3 (en) 2008-02-28
UY27454A1 (es) 2003-06-30
DK1503987T3 (da) 2007-03-12
EP1503987A2 (en) 2005-02-09
PA8553801A1 (es) 2003-07-28
WO2003029220A3 (en) 2004-11-11
US20030065010A1 (en) 2003-04-03
RS12004A (en) 2007-02-05
CY1105843T1 (el) 2011-02-02
CN1289485C (zh) 2006-12-13
EP1503987B1 (en) 2006-11-29
MXPA04002882A (es) 2004-07-02
PL373611A1 (en) 2005-09-05
BR0212916A (pt) 2004-10-13
CZ2004415A3 (cs) 2004-12-15
KR100629828B1 (ko) 2006-09-29
CA2461686A1 (en) 2003-04-10
ES2275902T3 (es) 2007-06-16
HUP0501098A2 (en) 2007-11-28
ATE346842T1 (de) 2006-12-15
JP2005505584A (ja) 2005-02-24
DE60216520D1 (de) 2007-01-11
US6573383B2 (en) 2003-06-03
HK1072424A1 (en) 2005-08-26
MY134349A (en) 2007-12-31
AR037325A1 (es) 2004-11-03

Similar Documents

Publication Publication Date Title
ECSP066559A (es)
MA29369B1 (fr) Dosage fixe d'anticorps anti-her
EA200702551A1 (ru) Способ получения эпоксида из хлоргидрина
CR8410A (es) Quinolinas utiles en el tratamiento de enfermedades cardiovasculares
WO2003006425A3 (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
BR0211905A (pt) Dialdeìdos de rapamicina
NO20052058D0 (no) Behandling av influensa.
WO2006091915A3 (en) Immunostimulatory oligonucleotides
CR9223A (es) 18-metil-19-nor-17-pregn-4-en-21, 17-carbolactonas,asi como preparaciones farmaceuticas que las contienen
MY142105A (en) Leukotriene biosynthesis inhibitors
ATE359279T1 (de) Moschus-geruchsstoffe
WO2006066950A3 (de) Tricyclische aminoalkohole, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer
SE9901077D0 (sv) Novel use
FR2924118B1 (fr) Fragments d'anticorps inhibiteurs de la proteine nef du vih.
ATE549024T1 (de) Chinazolin-kaliumkanalhemmer
ECSP056238A (es) Tableta que comprende fluvastatina y carmelosa de calcio.
UY27250A1 (es) Fenil-heterociclil-cteres
DE602005007858D1 (de) Medizinische seife
BR0008382A (pt) Formulação de liberação controlada para tratamento de copd
GT200200170A (es) Preparacion de inhibidor de cetp anhidro
BR0115139A (pt) Compostos bis-heterocìclicos com atividade antitumor e quimiossensibilizante
EA200400438A1 (ru) Применение ирбесартана для изготовления лекарств, которые пригодны для предупреждения или лечения лёгочной гипертонии
CY1109761T1 (el) Εντομοαπωθητικο μεσο
CR8185A (es) Pirimidinas 2- sustituidas
ATE489368T1 (de) Pyrimidinonverbindungen als calcilytica